课题基金 / 基金详情

CONSEQUENCES OF HUMAN PIT-1 AND GH PROMOTER MUTATIONS

CONSEQUENCES OF HUMAN PIT-1 AND GH PROMOTER MUTATIONS
人类 PIT-1 和 GH 启动子突变的后果
批准号:
2145496
负责人:
JOHN S. PARKS
金额:
$18.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-01-01 至 1996-12-31

项目摘要

项目成果

JOHN S. PARKS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pituitary growth hormone production is essential for normal postnatal growth. Recent studies in the applicant's laboratory have linked mutations of the Pit-1 gene to a human growth disorder involving deficiencies of the anterior pituitary hormones growth hormone, prolactin and thyrotropin. Humans with a substitution of proline for alanine at amino acid 158 differ from Snell dwarf mice with a mutation at amino acid 261 in that they have normal anterior pituitary size and only mild thyrotropin deficiency. The observation that an alteration in the POU-specific domain of Pit-1 eliminates transcriptional activation of its known target genes growth hormone and prolactin, with minimal impairment of binding to these genes and no impairment of anterior pituitary growth was not predicted by studies of mutant Pit-1 proteins produced in the laboratory. It suggests that sequence variation in the Pit-1 gene and its target gene promoters may account for a broader spectrum of human growth disorders. The proposed studies address this issue through examination of Pit-1 gene sequence in a large number of families with combined GH, Prl and TSH deficiencies, autosomal recessive isolated growth hormone deficiency, or autosomal dominant isolated growth hormone deficiency. The alternative possibility of an abnormality of regulatory elements in the growth hormone gene promoter is addressed through sequencing of the growth hormone promoter in families with autosomal recessive isolated growth hormone deficiency. Sequence variation is detected through polymerase chain reaction amplification of genomic DNA or cDNA and localized through direct DNA sequencing. The functional consequences of Pit-1 gene and growth hormone promoter sequence abnormalities are assessed by mobility shift DNA-binding assays, co-transfection of activator and reporter gene constructs in HeLa cells, and assays for activity of wild type and mutant Pit-1 in Adenovirus DNA replication assays. Studies of DNA sequence variation in children with severe disorders of growth are accompanied by studies of polymorphic variation in the same sequences among subjects at the extremes for normal growth. This project will define the importance of variations in Pit-1 and its target gene sequences in the pathogenesis of anterior pituitary hormone deficiency and in the generation of differences in patterns of growth among normal individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INHERITED GROWTH HORMONE DEFICIENCY
  • 批准号:
    6586037
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    JOHN S. PARKS
  • 依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
  • 批准号:
    6565742
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2001
  • 负责人:
    JOHN S. PARKS
  • 依托单位:
INHERITED GROWTH HORMONE DEFICIENCY
  • 批准号:
    6415360
  • 项目类别:
  • 资助金额:
    $29.31万
  • 财政年份:
    2000
  • 负责人:
    JOHN S. PARKS
  • 依托单位:
SAFETY OF NUTROPIN LIQUID--SOMATOTROPIN INJECTION
  • 批准号:
    6113151
  • 项目类别:
  • 资助金额:
    $3.88万
  • 财政年份:
    1998
  • 负责人:
    JOHN S. PARKS
  • 依托单位:
海外基金